Jon Sleightholme, director of Talent Acquisition Solutions, NFP, explores the hidden challenge of regulatory fast-tracking.
Shutterstock - Wolfilser
The launch of the regulatory innovation corridor between the UK’s Medicines and Healthcare products Regulatory Agency and Singapore’s Health Sciences Authority is an important moment for life sciences. It reflects a shared ambition to accelerate breakthrough therapies and streamline complex approval pathways.
For the industry, it represents opportunity. But it also intensifies a challenge that many organisations are already grappling with including how to attract, retain and manage the complex workforces that make regulatory acceleration possible.
Life sciences has never been a straightforward recruitment market. The professionals who understand regulatory strategy across jurisdictions, who can lead clinical development programmes, and who can interpret emerging technologies such as AI-enabled diagnostics are in short supply. When approval timelines compress and global collaboration increases, demand for that expertise rises further.
The companies that benefit most from regulatory acceleration won't just be those with the strongest science — they'll be those that move just as decisively on their people strategy.
A competitive market, sharpened further
The corridor doesn’t create the talent gap, it exposes it.
Regulatory affairs specialists with experience across multiple markets are rare. Clinical development leaders who understand both science and submission strategy are even rarer. Add in digital fluency and experience navigating AI-driven tools, and the talent pool becomes smaller still.
In this environment, recruitment processes matter. Organisations with lengthy, overly complex hiring journeys will struggle. When talent is scarce and in demand, candidates will not wait for slow decision-making or poorly coordinated interviews.
Recruitment is also expensive. But the real cost lies in attrition. Losing a specialist halfway through a submission, or six months into a fast-tracked programme, can disrupt timelines and create knowledge gaps that are difficult to replace. In a high-pressure regulatory environment, continuity is critical.
Beyond pay: what really differentiates employers
Compensation remains important. So do core benefits such as private medical cover for employees and their families, and a strong pension structure. These are expectations rather than advantages.
Where employers truly differentiate themselves is in how they design the broader employee experience — and whether what they promise matches what employees actually encounter.
Flexibility consistently ranks highly across workforce research. In life sciences, some roles must be site-based. Laboratory work can’t always be done remotely. But many regulatory, data and support roles allow for greater flexibility in how and where work is delivered.
Trust sits at the heart of this. During the pandemic, many organisations saw high levels of productivity. A sudden pivot to rigid working models can be interpreted by employees as a lack of confidence in them. In competitive markets, that perception carries weight.
Often, it’s the human considerations that tip the balance. The ability to flex hours to attend a family commitment, without penalty or suspicion, often matters more than marginal financial enhancements. These human considerations influence retention decisions every day.
Authenticity is equally important. Many organisations articulate strong employee value propositions, but the difference between those that succeed and those that struggle is whether those propositions are lived each day. Candidates and employees can quickly distinguish between a superficial promise and a culture that genuinely supports development, flexibility and wellbeing.
Purpose is not abstract
Life sciences has an inherent advantage: its mission is tangible.
For me, that mission is personal. Both of my step-parents were diagnosed with motor neurone disease. They were active, healthy people whose lives changed dramatically. Conversations with charities and researchers in that space highlight both the scale of the challenge and the extraordinary work being done to address it. I’m grateful for the work that the life sciences industry does that changes people’s lives each and every day.
When professionals working in regulatory or clinical development understand how their efforts accelerate treatments for conditions like this, their work takes on a deeper meaning. People want to see how their expertise contributes to outcomes that change lives.
That sense of purpose should be reinforced with clarity. Employees need line of sight to their role in the broader mission. They need visible career pathways and the opportunity to contribute ideas. Some of the most practical insights into improving processes come from those closest to the science and operations.
Retention in high-pressure environments
Fast-tracked programmes bring intensity. Timelines are tighter, expectations are higher, and the risk of burnout increases.
Retention in this context is about more than morale. It is about safeguarding progress.
Enhanced wellbeing support can make a meaningful difference. This may include faster access to mental health services, proactive stress management initiatives and leaders who are equipped to identify early signs of pressure within their teams.
Investment in development is equally important. Hiring externally can’t be the only response to evolving regulatory landscapes and emerging technologies. Organisations that commit to upskilling their existing teams, particularly in areas such as AI diagnostics and cross-border regulatory frameworks, build both capability and loyalty.
Employees who see structured opportunities to grow are more likely to remain engaged and committed.
Designing for diversity and geography
Cross-border collaboration introduces additional considerations. Benefits expectations may differ between UK-based professionals and those relocating or working across multiple jurisdictions. A rigid, one-size-fits-all structure rarely reflects the varied needs of a diverse workforce.
Flexibility within benefits design allows individuals to prioritise what matters most to them at different stages of life and career. Some may value enhanced healthcare coverage. Others may prioritise financial planning support, additional leave or family-focused benefits.
Understanding those nuances requires dialogue. Employers that listen to their workforce and adapt accordingly are better positioned to compete for scarce talent.
Talent strategy as infrastructure
The regulatory corridor is a positive development for patients and for innovation, but it raises the bar for employers.
An employee value proposition shouldn’t be just a marketing document. It should shape how organisations hire, develop and retain people. It should influence policy decisions, leadership behaviours and investment priorities.
In an uncertain economic and political environment, resilience matters. Building that resilience depends on investing in people as deliberately as in pipelines and partnerships.
Scientific progress depends on human capability. Organisations that recognise talent strategy as central to regulatory success, rather than peripheral to it, will be best placed to thrive in the next phase of life sciences innovation.